TM

Thomas Meier

Board Member

Newron Pharmaceuticals

Roles

Founder, Chairman of the Board and the Scientific Committee, Member of the Compensation and Audit & Compliance CommitteesatSanthera Pharmaceuticals

Newron Pharmaceuticals Pipeline

DrugIndicationPhase
Xadago® (safinamide)Parkinson's Disease (add-on to levodopa)Approved
Evenamide (NW-3509)Treatment-Resistant SchizophreniaPhase 3
SarizotanRett Syndrome (Respiratory Disturbances)Phase 3
Newron 1999Rare EpilepsyPreclinical